Access – Business & Investments

From product to patient

A biosimilar only improves health when it reaches patients at an affordable price. For Emerging Biopharmaceuticals manufacturers that means navigating procurement systems, building distribution partnerships and securing investment for the next product.

The hub works on both sides of the equation: opening markets for members' products, and bringing investors and funders closer to the projects that need them.

What the hub does

• Identifying investment opportunities in biosimilar projects and joint ventures between members.
• Organising roadshows, business meetings and investment events with global investors, including the Rio Health Forum and the Biosimilars LatAm series.
• The EBPMN Navigator — the network's Grant & Innovation Office — mapping funders and open calls and offering two-sided matchmaking for Global South projects.
• Market intelligence on trade flows, biosimilar market participation and licensing agreements, together with the Data Driver.